These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1696656)

  • 21. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal effects of the calcium channel blocker aranidipine and its active metabolite in anesthetized dogs and conscious spontaneously hypertensive rats.
    Ichihara K; Okumura K; Kamei H; Nagasaka M; Kanda A; Kanno T; Miyoshi K; Miyake H
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):277-85. PubMed ID: 9475270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pressure natriuresis after adrenomedullin in anesthetized spontaneously hypertensive rats.
    Kurashina T; Patel AR; Granger JP; Kirchner KA
    Hypertension; 1997 Sep; 30(3 Pt 2):660-3. PubMed ID: 9323000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
    Rosolová H; Cech J; Sefrna F
    Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
    Schölkens BA; Becker RH; Kaiser J
    Arzneimittelforschung; 1984; 34(10B):1417-25. PubMed ID: 6097268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
    Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of DuP 753 on renal function of normotensive and spontaneously hypertensive rats.
    Fenoy FJ; Milicic I; Smith RD; Wong PC; Timmermans PB; Roman R
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):321S-326S. PubMed ID: 1854459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.
    Oren S; Messerli FH; Grossman E; Garavaglia GE; Frohlich ED
    J Am Coll Cardiol; 1991 Apr; 17(5):1183-7. PubMed ID: 1826120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fosinopril/hydrochlorothiazide: single dose and steady-state pharmacokinetics and pharmacodynamics.
    O'Grady P; Yee KF; Lins R; Mangold B
    Br J Clin Pharmacol; 1999 Sep; 48(3):375-81. PubMed ID: 10510149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial.
    Xue C; Zhou C; Yang B; Lv J; Dai B; Yu S; Wang Y; Zhao G; Mei C
    BMJ Open; 2017 Feb; 7(2):e013672. PubMed ID: 28237959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive rats.
    Fenoy FJ; Milicic I; Mistry M; Mecca TE; Roman RJ
    J Pharmacol Exp Ther; 1992 May; 261(2):470-5. PubMed ID: 1578362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive effects of a novel endothelin-A receptor antagonist in rats.
    Bird JE; Moreland S; Waldron TL; Powell JR
    Hypertension; 1995 Jun; 25(6):1191-5. PubMed ID: 7768562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of SC-56525, a potent, orally active renin inhibitor, in salt-depleted and renal hypertensive dogs.
    McMahon EG; Yang PC; Babler MA; Bittner SE; Suleymanov OD; Cain-Janicki KJ; Bedell LJ; Hanson GJ; Cook CS
    Hypertension; 1995 Jul; 26(1):95-100. PubMed ID: 7607739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal nerves promote sodium excretion in angiotensin-induced hypertension.
    Lohmeier TE; Hildebrandt DA
    Hypertension; 1998 Jan; 31(1 Pt 2):429-34. PubMed ID: 9453340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril).
    Baum T; Watkins RW; Sybertz EJ; Ahn HS; Nelson S; Coleman W; Tedesco R; Pula KK; Rivelli M; Sabin C
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):230-45. PubMed ID: 2884941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal renal vascular responses to dipyridamole-induced vasodilation in spontaneously hypertensive rats.
    Susic D; Varagic J; Frohlich ED
    Hypertension; 2001 Mar; 37(3):894-7. PubMed ID: 11244014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.